Zeitschriftenaufsatz
|
2023
Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib.
Autor:in
Prokoph, Nina; Matthews, Jamie D; Trigg, Ricky M; Montes-Mojarro, Ivonne A; Burke, G A Amos; Fend, Falko; Merkel, Olaf; Kenner, Lukas; Geoerger, Birgit; Johnston, Robert; Murray, Matthew J; Riguad, Charlotte; Brugières, Laurence; Turner, Suzanne D
Publikationen als Autor:in / Herausgeber:in der Vetmeduni
Journal
Schlagwörter
Child; Humans; Anaplastic Lymphoma Kinase; Crizotinibpharmacologytherapeutic use; Carcinoma, Non-Small-Cell Lung; Receptor Protein-Tyrosine Kinasestherapeutic use; Lymphoma, Large-Cell, Anaplasticdrug therapypathology; Heterografts; Lung Neoplasmsdrug therapy; Neoplasm Recurrence, Localdrug therapy; Organophosphorus Compoundspharmacologytherapeutic use; Protein Kinase Inhibitorstherapeutic use
Dokumententyp
Originalarbeit
CC Lizenz
CCBY
Open Access Type
Hybrid
ISSN/eISSN
0007-1048 - 1365-2141
10.1111/bjh.18953
WoS ID
PubMed ID
Repository Phaidra